FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 62 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,491,095 | -29.2% | 2,898,219 | -0.3% | 0.00% | -50.0% |
| Q2 2023 | $20,470,384 | -45.2% | 2,907,725 | -51.8% | 0.00% | 0.0% |
| Q1 2023 | $37,386,154 | +88.0% | 6,030,024 | +93.4% | 0.00% | 0.0% |
| Q4 2022 | $19,888,973 | -32.1% | 3,117,394 | -8.8% | 0.00% | -33.3% |
| Q3 2022 | $29,312,000 | -37.2% | 3,416,332 | -0.5% | 0.00% | -40.0% |
| Q2 2022 | $46,701,000 | -4.1% | 3,433,878 | +7.4% | 0.01% | +25.0% |
| Q1 2022 | $48,673,000 | -14.4% | 3,195,866 | +28.6% | 0.00% | 0.0% |
| Q4 2021 | $56,828,000 | +61.9% | 2,484,834 | -1.4% | 0.00% | +33.3% |
| Q3 2021 | $35,105,000 | +29.5% | 2,520,134 | -0.8% | 0.00% | +50.0% |
| Q2 2021 | $27,106,000 | -18.4% | 2,540,434 | -1.3% | 0.00% | -33.3% |
| Q1 2021 | $33,200,000 | -33.8% | 2,573,034 | -0.3% | 0.00% | -25.0% |
| Q4 2020 | $50,118,000 | – | 2,580,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $16,623,000 | 5.56% |
| Flagship Pioneering Inc. | 12,674,120 | $167,045,000 | 2.68% |
| Birchview Capital, LP | 314,143 | $4,140,000 | 2.46% |
| Monashee Investment Management LLC | 530,581 | $6,993,000 | 1.08% |
| Artal Group S.A. | 1,720,720 | $22,679,000 | 0.40% |
| Octagon Capital Advisors LP | 69,132 | $911,000 | 0.34% |
| Cormorant Asset Management, LP | 1,000,000 | $13,180,000 | 0.29% |
| Alphabet Inc. | 500,901 | $6,602,000 | 0.27% |
| Casdin Capital, LLC | 216,216 | $2,850,000 | 0.08% |
| Board of Trustees of The Leland Stanford Junior University | 30,657 | $404,000 | 0.04% |